Wells Fargo Portfolio holdings
Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.68B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$945M |
| 3 |
American Express
AXP
|
+$595M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$277M |
| 5 |
Vanguard Intermediate-Term Bond ETF
BIV
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.59B |
| 2 |
UnitedHealth
UNH
|
+$795M |
| 3 |
Nike
NKE
|
+$444M |
| 4 |
Target
TGT
|
+$401M |
| 5 |
NVIDIA
NVDA
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.55% |
| 2 | Financials | 8.46% |
| 3 | Industrials | 5.78% |
| 4 | Healthcare | 5.47% |
| 5 | Consumer Discretionary | 5.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5276
Certara
CERT
$1.26B
| $57.4K | ﹤0.01% |
4,903
+2,408
| +97% | +$28.5K |
|
5277
MicroSectors FANG+ ETNs due Jan 8 2038
FNGS
$599M
| $57.3K | ﹤0.01% |
+880
| New | +$49.7K |
|
5278
DiaMedica Therapeutics
DMAC
$360M
| $57.1K | ﹤0.01% |
14,652
+13,652
| +1,365% | +$53.2K |
|
5279
Nkarta
NKTX
$157M
| $57K | ﹤0.01% |
34,322
+2,563
| +8% | +$4.7K |
|
5280
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.24B
| $56.7K | ﹤0.01% |
1,242
-3,592
| -74% | -$154K |
|
5281
Innovator US Equity Power Buffer ETF May
PMAY
$817M
| $56.7K | ﹤0.01% |
1,500
-200
| -12% | -$7.24K |
|
5282
Schwab Fundamental International Small Company Index ETF
FNDC
$3.13B
| $56.2K | ﹤0.01% |
1,336
-21
| -2% | -$814 |
|
5283
NI Holdings
NODK
$318M
| $56K | ﹤0.01% |
4,394
-289
| -6% | -$3.73K |
|
5284
Transcontinental Realty Investors
TCI
$353M
| $55.8K | ﹤0.01% |
1,309
+476
| +57% | +$16.2K |
|
5285
Zevia
ZVIA
$125M
| $55.7K | ﹤0.01% |
17,308
+16,308
| +1,631% | +$42.9K |
|
|
HUYA
5286
Huya Inc
HUYA
$565M
| $55.7K | ﹤0.01% |
15,825
+5,325
| +51% | +$19.3K |
|
5287
State Street Fixed Income Sector Rotation ETF
FISR
$494M
| $55K | ﹤0.01% |
2,130
+55
| +3% | +$1.4K |
|
5288
Mind CTI
MNDO
$21.6M
| $54.7K | ﹤0.01% |
39,937
+11,205
| +39% | +$17.2K |
|
5289
Arrow Dow Jones Global Yield ETF
GYLD
$37.5M
| $54.6K | ﹤0.01% |
4,161
-1,114
| -21% | -$14.2K |
|
5290
Designer Brands
DBI
$340M
| $54.6K | ﹤0.01% |
22,946
+1,167
| +5% | +$3.52K |
|
5291
YPF
YPF
$19.3B
| $54.5K | ﹤0.01% |
1,732
-1,164
| -40% | -$38.8K |
|
|
ALAR
5292
Alarum Technologies
ALAR
$14.6M
| $54.1K | ﹤0.01% |
4,000
-1,000
| -20% | -$8.35K |
|
5293
Korro Bio
KRRO
$166M
| $54.1K | ﹤0.01% |
4,333
+540
| +14% | +$7.78K |
|
5294
Knightscope
KSCP
$26.7M
| $53.4K | ﹤0.01% |
10,800
| – | – |
|
5295
Protalix BioTherapeutics
PLX
$194M
| $53.3K | ﹤0.01% |
+36,034
| New | +$73.7K |
|
|
ARIS
5296
Aris Mining
ARIS
$3.29B
| $53.1K | ﹤0.01% |
+7,908
| New | +$46.9K |
|
5297
PUT
EPAM Systems
EPAM
$5.77B
| $53K | ﹤0.01% |
300
+100
| +50% | +$16.7K |
|
5298
Quantum Corp
QMCO
$462M
| $53K | ﹤0.01% |
5,315
+4,740
| +824% | +$52.4K |
|
|
SLSN
5299
Solesence Inc
SLSN
$72.8M
| $52.8K | ﹤0.01% |
+12,120
| New | +$42.6K |
|
5300
Smith-Midland
SMID
$146M
| $52.7K | ﹤0.01% |
1,569
-614
| -28% | -$18.7K |
|
Similar funds
Wells Fargo's Q2 2025 Portfolio in Review
As of Q2 2025, Wells Fargo held 7,476 positions worth $483B, up 9.8% from $440B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Wells Fargo's Q2 2025 filing shows 545 new, 3,252 increased, 2,335 reduced and 433 closed positions. Its largest new stake was VanEck Pharmaceutical ETF: 402,987 shares worth $35.4M. The largest sale was Invesco QQQ Trust, an estimated $1.59B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.
- Wells Fargo's largest Q2 2025 buy was VanEck Pharmaceutical ETF: 402,987 shares worth $35.4M.
- Wells Fargo added most to State Street SPDR S&P 500 ETF Trust in Q2 2025, an estimated $3.68B increase.
- Wells Fargo's biggest Q2 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.59B.
- Wells Fargo fully exited Discover Financial Services in Q2 2025, selling an estimated $55.9M.
- Wells Fargo's ten largest holdings make up 20% of its $483B portfolio in Q2 2025.
- Wells Fargo opened 545 new positions and closed 433 in Q2 2025.
- Wells Fargo's portfolio value rose 9.8% quarter-over-quarter to $483B.
Based on Wells Fargo's 13F filing for Q2 2025, filed 14 Aug 2025.